XENON PHARMACEUTICALS INC (XENE) - Insider Holders & Insider Ownership

List of insiders holdings for XENON PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1MX Associates LLP
10% Owner		2015-01-07 12:57:301,474,660
0		1,474,660Form 4
2BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner		2023-02-13 20:20:161,271,243
0		1,271,243Form 13G
3STEIN EVAN A.
Director		2017-02-13 09:17:32443,916
0		443,916Form 13G
4HOLLER FRANK A
Director		2021-06-01 16:07:31143,653
1,184		144,837Form 4
5Von Seggern Christopher
Chief Commercial Officer		2024-03-12 18:42:52100,000
0		100,000Form 4
6TARNOW MICHAEL M
Director		2021-05-20 16:18:4477,942
0		77,942Form 4
7AZAB MOHAMMAD
Director		2023-12-20 17:04:2374,225
0		74,225Form 4
8AYCARDI-FONSECA ERNESTO
CMO		2020-03-13 17:06:3865,000
0		65,000Form 4
9ROBIN SHERRINGTON
EVP, Strategy & Innovation		2024-03-12 18:35:5965,000
0		65,000Form 4
10EMPFIELD JAMES R.
EVP, Drug Discovery		2024-03-12 18:37:2565,000
0		65,000Form 4
11MORTIMER IAN
PRESIDENT & CEO		2026-10-01 09:19:2849,923
14,300		64,223Form 4
12Cline Darren S
Chief Commercial Officer		2026-01-09 18:53:1360,000
0		60,000Form 4
13Kelly Thomas Patrick
Chief Financial Officer		2026-10-16 20:22:1945,000
0		45,000Form 4
14CORRAINI KAREN G.
Gen. Counsel & Corp. Secretary		2015-03-19 20:52:2735,000
0		35,000Form 4
15Svoronos Dawn
Director		2026-09-03 20:26:1831,373
0		31,373Form 4
16PATOU GARY
Director		2026-06-08 21:19:4524,896
4,902		29,798Form 4
17DiFabio Andrea
Chief Legal Officer		2026-03-13 20:16:4318,551
0		18,551Form 4
18PIMSTONE SIMON N.
Director		2023-06-02 17:21:1418,475
0		18,475Form 4
19SCHELLER RICHARD H
Director		2019-09-18 19:39:0915,000
0		15,000Form 4
20Machado Patrick
Director		2026-06-03 21:04:4514,745
0		14,745Form 4
21Gover Justin D.
Director		2026-06-03 21:04:3114,745
0		14,745Form 4
22GAROFALO ELIZABETH A.
Director		2026-06-03 21:04:1414,745
0		14,745Form 4
23GOLDBERG Y. PAUL
SVP, Clinical Development		2017-10-24 18:45:3211,000
0		11,000Form 4
24Hayden Michael R
Director		2021-06-03 21:07:4810,000
0		10,000Form 4
25Desjardins Clarissa
Director		2020-06-02 16:58:0810,000
0		10,000Form 4
26COHEN CHARLES J.
VP, Biology		2018-12-13 13:56:506,550
0		6,550Form 4
27AULIN SHERRY
Chief Financial Officer		2024-12-19 18:57:426,000
0		6,000Form 4
28Bridger Gary
EVP, Research & Development		2014-11-25 21:20:385,144
0		5,144Form 4
29Evans Johnston L
Director		2015-05-06 15:46:213,086
0		3,086Form 4
30GANNON STEVEN
Director		2026-08-13 16:33:271,870
0		1,870Form 4
31Cannon Gillian
Director		2026-06-08 21:19:231,455
0		1,455Form 4
32WINQUIST RAYMOND
Head, Translational Research		2017-08-21 16:48:271000
0		1000Form 4
33KENNEY CHRISTOPHER JOHN
Chief Medical Officer		2026-08-31 21:59:362
0		2Form 4